Takeda U.S. Financing (TUSFI), a financing subsidiary of S&C client Takeda Pharmaceutical Company Limited (Takeda), completed an SEC-registered offering of $2.4 billion of senior guaranteed debt securities, consisting of $1.65 billion of 5.2% guaranteed notes due 2035 and $750 million of 5.9% guaranteed notes due 2055.
The offering marks TUSFI’s inaugural offering and Takeda’s third SEC-registered debt offering.
Takeda is a Japan-headquartered global pharmaceutical company specializing in the research, development, production and global commercialization of pharmaceutical products.
The S&C team representing TUSFI and Takeda included Keiji Hatano, Nirav Mehta, Xiaoyu Duan and Robert Okada. Jeff Hochberg and Saul Brander advised on tax matters. Vanessa Blackmore, Ruby Avison, Siddhant Iyer and trainee solicitor Alex Goulding advised on UK law- and EU law-related matters.